|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 76, 601-603, Copyright © 1979 by American College of Chest Physicians
ARTICLES |
B Person and RJ Proctor
Primary pulmonary hypertension remains a difficult therapeutic problem. Sublingual isoproterenol (Isuprel) has been effective in a few cases but the every-two-hour dosage schedule is inconvenient on a long-term basis. A case of primary pulmonary hypertension is described in which terbutaline sulfate and indomethacin were given a trial. There was no sustained response to terbutaline but there seemed to be a response to indomethacin and isoproterenol.
This article has been cited by other articles:
![]() |
M Y Mok, H F Tse, and C S Lau Pulmonary hypertension secondary to systemic lupus erythematosus: prolonged survival following treatment with intermittent low dose iloprost Lupus, May 1, 1999; 8(4): 328 - 331. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |